Advice for appropriate causal model and analysis method
|
|
11
|
739
|
October 27, 2024
|
Randomized non-comparative trials: an oxymoron?
|
|
16
|
998
|
October 15, 2024
|
Interpreting the coefficient of a log transformed dependent variable
|
|
2
|
358
|
September 11, 2024
|
Causal inferences from RCTs- could “toy” clinical examples promote understanding?
|
|
13
|
681
|
September 2, 2024
|
Individual response
|
|
247
|
40905
|
August 21, 2024
|
Summary table of different Cox PHM models to compare them
|
|
3
|
288
|
August 12, 2024
|
Use of percentage change in clinical trials
|
|
17
|
3870
|
July 22, 2024
|
Evaluating seizures in open-label studies
|
|
8
|
741
|
July 21, 2024
|
Appropriate to do lasso, then standard glm using variables with non-zero coef. from lasso?
|
|
1
|
369
|
July 2, 2024
|
Estimands from zero-inflated regression model
|
|
9
|
751
|
June 20, 2024
|
ITT analysis under equally high non-adherence in both arms in RCT
|
|
4
|
556
|
June 9, 2024
|
Can we think of competing-event as another form of non-event in terms of utility?
|
|
0
|
537
|
April 21, 2024
|
Overall survival vs disease-free survival and other surrogate endpoints
|
|
5
|
7405
|
April 11, 2024
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
675
|
February 23, 2024
|
Review of Trial at the Center of the Firestorm Over Early Connection of Patients to Ventilators during the Pandemic
|
|
34
|
3938
|
February 16, 2024
|
Does subtracting/or not, the mean-rank in Wilcoxon-Mann-Whitney make any difference?
|
|
4
|
704
|
February 1, 2024
|
Ranked analysis of ANCOVA
|
|
7
|
1802
|
January 21, 2024
|
AUC of each subgroup is smaller than overall AUC
|
|
7
|
4754
|
November 13, 2023
|
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times
|
|
2
|
1018
|
October 3, 2023
|
About the interpret category
|
|
1
|
3231
|
October 3, 2023
|
Comparing "all active dose" to placebo - do we treat "all active dose" as one group or separate groups?
|
|
2
|
930
|
September 4, 2023
|
Guidance of analysis of longitudinal patient reported outcomes w.r.t Joint models
|
|
4
|
1154
|
August 29, 2023
|
Design of Experiments in Economics vs Medicine: a Decision Theory POV
|
|
6
|
2112
|
July 27, 2023
|
Inferences from summary data - without seeing the data for a Cox PH model, do chi square tests tell us anything?
|
|
5
|
484
|
July 24, 2023
|
Case-control study with and corresponding subgroup
|
|
2
|
792
|
July 20, 2023
|
Impact of Model Intercepts on Ordinal Logistic Regression Outcome
|
|
7
|
1529
|
June 22, 2023
|
P values and small sample size
|
|
6
|
1008
|
June 20, 2023
|
Minimum PPV/NPV values to reach positive net benefit and net benefit avoided
|
|
10
|
1499
|
June 12, 2023
|
Outlier detection
|
|
3
|
1437
|
May 11, 2023
|
HR really close to 1 but significant - how to interpret and report?
|
|
9
|
1672
|
April 25, 2023
|